InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 3 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding InMed Pharmaceuticals Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 10 | 17 | +7 |
| Shares | 26.9K | 804.3K | +777.4K (+2,890.6%) |
| Value | $18.6K | $334.4K | +$315.8K (+1,702.5%) |
New holders (9)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 511,934 | $213.0K | 1.88% |
| Armistice Capital, LLC | 205,968 | $85.7K | 0.00% |
| Renaissance Technologies LLC | 38,900 | $16.0K | 0.00% |
| Citadel Advisors LLC | 34,009 | $14.1K | 0.00% |
| Two Sigma Securities, LLC | 12,894 | $5.36K | 0.00% |
| Qube Research & Technologies Ltd | 200 | $83 | 0.00% |
| Bank of America Corp | 100 | $42 | 0.00% |
| Advisory Services Network, LLC | 59 | $25 | 0.00% |
| Global Retirement Partners, LLC | 6 | $2 | 0.00% |
Sold out (2)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 26,589 | $18.3K |
| UBS Group AG | 69 | $48 |